Skip to main content
Clinical Trials/NCT00809445
NCT00809445
Completed
Phase 3

HIV Rapid Testing and Counseling in Drug Abuse Treatment Programs in the U.S.

University of Miami12 sites in 1 country1,281 target enrollmentJanuary 2009

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Substance-Related Disorders
Sponsor
University of Miami
Enrollment
1281
Locations
12
Primary Endpoint
Self-Report Receipt of HIV Test Results
Status
Completed
Last Updated
10 years ago

Overview

Brief Summary

This is a randomized controlled clinical trial in which adults receiving drug abuse treatment will be recruited to participate in a multi-center HIV testing and counseling study. The purpose of this study is to assess the relative effectiveness of three HIV testing strategies on increasing receipt of test results: (1) on-site HIV rapid testing with brief, participant-tailored prevention counseling, (2) on-site HIV rapid testing with information only, and (3) referral for off-site HIV testing. The study will also assess the effectiveness of the three testing strategies in reducing HIV risk behaviors.

Detailed Description

This is a randomized controlled clinical trial in which individuals receiving drug abuse treatment will be recruited to participate in a multi-center HIV testing and counseling study. The purpose of this study is to assess the relative effectiveness of three HIV testing strategies on increasing receipt of HIV test results: (1) on-site HIV rapid testing with brief, participant-tailored prevention counseling, (2) on-site HIV rapid testing with information only, and (3) referral for off-site HIV testing. The study will also assess the effectiveness of the three testing strategies in reducing HIV sexual risk behaviors. Injection drug risk behavior will be a secondary outcome. Participants will complete a baseline assessment to report their demographics, HIV testing history and sexual and drug-using risk behaviors, and will be randomized to one of three groups. At one month post-randomization, participants will complete a follow-up assessment to determine whether or not they received their HIV test results. At six months post-randomization, participants will complete a follow-up assessment to assess any changes in their HIV sexual risk behaviors.

Registry
clinicaltrials.gov
Start Date
January 2009
End Date
February 2010
Last Updated
10 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Daniel J Feaster

Associate Professor of Biostatistics

University of Miami

Eligibility Criteria

Inclusion Criteria

  • At least 18 years of age
  • HIV-negative or HIV status unknown
  • No receipt of results from HIV test initiated within last 12 months
  • Be able to communicate in English

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Self-Report Receipt of HIV Test Results

Time Frame: One month post-randomization

The HIV testing primary outcome is self-reported receipt of HIV test results. This will be measured at one month post-randomization for all participants. We recognize that there are three potential HIV testing behaviors that could be evaluated in this study: acceptance of HIV testing, completion of HIV testing, and receipt of HIV testing results. Acceptance of testing refers to whether or not a participant would accept the offer of an HIV test. Completion of testing refers to whether or not a participant completes the HIV test. Receipt of HIV test results refers to whether or not a participant self-reports having received the results of the HIV test.

Number of Risky Sexual Behaviors

Time Frame: Six months post-randomization

The sexual risk behavior primary outcome is self-reported sexual risk behavior, which will be measured at baseline and six months post-randomization as the self-reported number of unprotected sex acts (vaginal or anal sex without a condom).

Secondary Outcomes

  • Sharing of Needles Used in Drug Use(Six months)
  • Self-Report of Ever Having Been Tested(1 month post-randomization)

Study Sites (12)

Loading locations...

Similar Trials